#Low-density lipoprotein (LDL) belongs to the lipoprotein particle family. Its size is approx. 22 nm but since LDL particles contain a changing number of fatty acids they actually have a mass and size distribution. Each native LDL particle contains a single apolipoprotein B-100 molecule (Apo B-100, a protein with 4536 amino acid residues) that circles the fatty acids keeping them soluble in the aqueous environment..
#(S1 (S (NP (NP (NN Low-density) (NN lipoprotein)) (PRN (-LRB- -LRB-) (NP (NNP LDL)) (-RRB- -RRB-))) (VP (VBZ belongs) (PP (TO to) (NP (DT the) (JJ lipoprotein) (NN particle) (NN family.) (SBAR (S (S (NP (PRP$ Its) (NN size)) (VP (AUX is) (VP (VBG approx.) (NP (CD 22) (NN nm))))) (CC but) (S (SBAR (IN since) (S (NP (NNP LDL) (NNS particles)) (VP (VBP contain) (NP (NP (DT a) (VBG changing) (NN number)) (PP (IN of) (NP (JJ fatty) (NNS acids))))))) (NP (PRP they)) (ADVP (RB actually)) (VP (AUX have) (NP (NP (DT a) (NN mass) (CC and) (NN size) (NNS distribution.)) (SBAR (S (NP (DT Each) (JJ native) (NNP LDL) (NN particle)) (VP (VBZ contains) (NP (NP (NP (DT a) (JJ single) (NN apolipoprotein)) (NNP B-100) (NN molecule)) (PRN (-LRB- -LRB-) (NP (NNP Apo) (NNP B-100)) (, ,) (NP (NP (DT a) (NN protein)) (PP (IN with) (NP (CD 4536) (JJ amino) (NN acid) (NNS residues)))) (-RRB- -RRB-)) (SBAR (WHNP (WDT that)) (S (VP (VBZ circles) (S (NP (DT the) (NN fatty) (NNS acids)) (VP (VBG keeping) (S (NP (PRP them)) (ADJP (JJ soluble) (PP (IN in) (NP (DT the) (JJ aqueous) (NN environment)))))))))))))))) (. .))))))) (. .)))
#Rule:Nouns
r1Low-densityNN
r1lipoproteinNN
r1LDLLocationAnnotation
r1particleNN
r1familyNN
r1sizeNN
r1nmNN
r1LDLOrganizationAnnotation
r1particlesNNS
r1numberNN
r1acidsNNS
r1massNN
r1sizeNN
r1distributionNNS
r1LDLNNP
r1particleNN
r1apolipoproteinNN
r1B-100NNP
r1moleculeNN
r1ApoLocationAnnotation
r1B-100NNP
r1proteinNN
r1acidNN
r1residuesNNS
r1fattyNN
r1acidsNNS
r1environmentNN

#Rule:Verbs
r2belongsVBZ
r2approxVBG
r2containVBP
r2changingVBG
r2containsVBZ
r2circlesVBZ
r2keepingVBG

#Rule:Adjs
r4lipoproteinJJ
r4fattyJJ
r4nativeJJ
r4singleJJ
r4aminoJJ
r4solubleJJ
r4aqueousJJ

#Rule:Adj-Noun
r5lipoproteinJJfamilyNN
r522CDnmNN
r5changingVBGnumberNN
r5fattyJJacidsNNS
r5nativeJJparticleNN
r5singleJJapolipoproteinNN
r54536CDresiduesNNS
r5aminoJJresiduesNNS
r5aqueousJJenvironmentNN

#Rule:PRP-Noun
r6itsPRP$sizeNN

#Rule:N-HeadNoun
r8Low-densityNNlipoproteinNN
r8particleNNfamilyNN
r8LDLOrganizationAnnotationparticlesNNS
r8sizeNNdistributionNNS
r8LDLNNPparticleNN
r8B-100NNPmoleculeNN
r8ApoLocationAnnotationB-100NNP
r8acidNNresiduesNNS
r8fattyNNacidsNNS

#Rule:HeadNoun-V
r11lipoproteinNNbelongsVBZ
r11sizeNNapproxVBG
r11theyPRPhaveAUX
r11particlesNNScontainVBP
r11particleNNcontainsVBZ
r11acidsNNSkeepingVBG

#Rule:HeadNoun-(who/that)-V
r14moleculeNNcirclesVBZ

#Rule:V-HeadNoun
r21approxVBGnmNN
r21containVBPnumberNN
r21haveAUXdistributionNNS
r21containsVBZmoleculeNN

#Rule:V-HeadNoun
r22circlesVBZacidsNNS
r22keepingVBGthemPRP

#Rule:PPinNP
r26numberNNofINacidsNNS
r26proteinNNwithINresiduesNNS

#Rule:PPinVP
r30belongsVBZtoTOfamilyNN

#Rule:PPinADJP
r37solubleJJinINenvironmentNN

#Rule:V-ADV
r46haveAUXactuallyRB

#Because LDLs transport cholesterol to the arteries and can be retained there by arterial proteoglycans starting the formation of plaques, increased levels are associated with atherosclerosis, and thus heart attack, stroke and peripheral vascular disease. This is why cholesterol inside LDL lipoproteins is called bad cholesterol. Still, it is not the cholesterol that is bad; it is instead how and where it is being transported, and in what amounts over time..
#(S1 (S (S (SBAR (IN Because) (S (VP (VP (VBZ LDLs) (NP (NN transport) (NN cholesterol)) (PP (TO to) (NP (DT the) (NNS arteries)))) (CC and) (VP (MD can) (VP (AUX be) (VP (VBN retained) (ADVP (RB there)) (PP (IN by) (NP (NP (JJ arterial) (NNS proteoglycans)) (VP (VBG starting) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NNS plaques))))))))))))) (, ,) (NP (VBN increased) (NNS levels)) (VP (AUX are) (VP (VBN associated) (PP (IN with) (NP (NN atherosclerosis)))))) (, ,) (CC and) (S (ADVP (RB thus)) (NP (NP (NP (NN heart) (NN attack)) (, ,) (NP (NN stroke)) (CC and) (NP (JJ peripheral) (NN vascular))) (PP (FW disease.) (NP (DT This)))) (VP (AUX is) (SBAR (WHADVP (WRB why)) (S (NP (NP (NN cholesterol)) (PP (IN inside) (NP (NNP LDL) (NNS lipoproteins)))) (VP (AUX is) (VP (VBN called) (S (NP (JJ bad) (NNS cholesterol.) (S (S (ADVP (RB Still)) (, ,) (NP (PRP it)) (VP (AUX is) (RB not) (NP (NP (DT the) (NN cholesterol)) (SBAR (WHNP (WDT that)) (S (VP (AUX is) (ADJP (JJ bad)))))))) (: ;) (S (NP (PRP it)) (VP (AUX is) (UCP (SBAR (WHADVP (RB instead) (WRB how) (CC and) (WRB where)) (S (NP (PRP it)) (VP (AUX is) (VP (AUXG being) (VP (VBN transported)))))) (, ,) (CC and) (PP (IN in) (SBAR (WHNP (WP what)) (S (VP (VBZ amounts) (PP (IN over) (NP (NN time)))))))))) (. .)))))))))) (. .)))
#Rule:Nouns
r1transportNN
r1cholesterolNN
r1arteriesNNS
r1proteoglycansNNS
r1formationNN
r1plaquesNNS
r1levelsNNS
r1atherosclerosisNN
r1heartNN
r1attackNN
r1strokeNN
r1vascularNN
r1cholesterolNN
r1LDLNNP
r1lipoproteinsNNS
r1cholesterolNNS
r1cholesterolNN
r1timeNN

#Rule:Verbs
r2LDLsOrganizationAnnotation
r2retainedVBN
r2startingVBG
r2increasedVBN
r2associatedVBN
r2calledVBN
r2transportedVBN
r2amountsVBZ

#Rule:Adjs
r4arterialJJ
r4peripheralJJ
r4badJJ
r4badJJ

#Rule:Adj-Noun
r5arterialJJproteoglycansNNS
r5increasedVBNlevelsNNS
r5peripheralJJvascularNN
r5badJJcholesterolNNS

#Rule:N-HeadNoun
r8transportNNcholesterolNN
r8heartNNattackNN
r8LDLNNPlipoproteinsNNS

#Rule:N-ApposN
r10attackNNstrokeNN

#Rule:HeadNoun-V
r11proteoglycansNNSstartingVBG
r11attackNNisAUX
r11strokeNNisAUX
r11vascularNNisAUX
r11itPRPisAUX
r11itPRPisAUX

#Rule:V-By-Agent
r13proteoglycansNNSretainedVBN

#Rule:HeadNoun-(who/that)-V
r14cholesterolNNisAUX

#Rule:V-HeadNoun
r21LDLsOrganizationAnnotationcholesterolNN
r21startingVBGformationNN
r21isAUXcholesterolNN

#Rule:V-HeadNoun
r22calledVBNcholesterolNNS

#Rule:V-HeadNoun(passive)
r23associatedVBNlevelsNNS
r23calledVBNcholesterolNN
r23transportedVBNitPRP

#Rule:V-ADJ
r25isAUXbadJJ

#Rule:PPinNP
r26formationNNofINplaquesNNS
r26cholesterolNNinsideINlipoproteinsNNS

#Rule:PPinVP
r30LDLsOrganizationAnnotationtoTOarteriesNNS
r30amountsVBZoverINtimeNN

#Rule:PPinVP
r32associatedVBNwithINatherosclerosisNN

#Rule:V-ADV
r46retainedVBNthereRB
r46isAUXthusRB
r46isAUXStillRB
r46isAUXnotRB

#Increasing evidence has revealed that the concentration and size of the LDL particles more powerfully relates to the degree of atherosclerosis progression than the concentration of cholesterol contained within all the LDL particles[citation needed].
#(S1 (S (NP (VBG Increasing) (NN evidence)) (VP (AUX has) (VP (VBN revealed) (SBAR (IN that) (S (NP (NP (DT the) (NN concentration) (CC and) (NN size)) (PP (IN of) (NP (DT the) (NNP LDL) (NNS particles)))) (ADVP (RBR more) (RB powerfully)) (VP (VBZ relates) (PP (TO to) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NP (NN atherosclerosis) (NN progression)) (PP (IN than) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NN cholesterol))) (VP (VBN contained) (PP (IN within) (NP (NP (PDT all) (DT the) (JJ LDL) (NN particles[citation)) (VP (VBN needed) (S (ADJP (JJ -RSB-)))))))))))))))))) (. .)))
#Rule:Nouns
r1evidenceNN
r1concentrationNN
r1sizeNN
r1LDLOrganizationAnnotation
r1particlesNNS
r1degreeNN
r1atherosclerosisNN
r1progressionNN
r1concentrationNN
r1cholesterolNN
r1particles[citationNN

#Rule:Verbs
r2increasingVBG
r2revealedVBN
r2relatesVBZ
r2containedVBN
r2neededVBN

#Rule:Adjs
r4LDLOrganizationAnnotation
r4]JJ

#Rule:Adj-Noun
r5increasingVBGevidenceNN
r5LDLOrganizationAnnotationparticles[citationNN

#Rule:N-HeadNoun
r8LDLOrganizationAnnotationparticlesNNS
r8atherosclerosisNNprogressionNN

#Rule:HeadNoun-V
r11concentrationNNrelatesVBZ

#Rule:HeadNoun-V
r12evidenceNNrevealedVBN

#Rule:V-HeadNoun(passive)
r24containedVBNconcentrationNN
r24neededVBNparticles[citationNN

#Rule:PPinNP
r26concentrationNNofINparticlesNNS
r26degreeNNofINprogressionNN
r26progressionNNthanINconcentrationNN
r26concentrationNNofINcholesterolNN

#Rule:PPinVP
r30relatesVBZtoTOdegreeNN

#Rule:PPinVP
r32containedVBNwithinINparticles[citationNN

#Rule:V-IN-V
r43revealedVBNthatINrelatesVBZ

#Rule:V-ADV
r46relatesVBZpowerfullyRB

# The healthiest pattern, though relatively rare, is to have small numbers of large LDL particles and no small particles.
#(S1 (S (NP (DT The) (JJS healthiest) (NN pattern)) (PRN (, ,) (SBAR (IN though) (S (ADJP (RB relatively) (JJ rare)))) (, ,)) (VP (AUX is) (S (VP (TO to) (VP (AUX have) (NP (NP (JJ small) (NNS numbers)) (PP (IN of) (NP (NP (JJ large) (NNP LDL) (NNS particles)) (CC and) (NP (DT no) (JJ small) (NNS particles))))))))) (. .)))
#Rule:Nouns
r1patternNN
r1numbersNNS
r1LDLLocationAnnotation
r1particlesNNS
r1particlesNNS

#Rule:Adjs
r4healthiestJJS
r4rareJJ
r4smallJJ
r4largeJJ
r4smallJJ

#Rule:Adj-Noun
r5healthiestJJSpatternNN
r5smallJJnumbersNNS
r5largeJJparticlesNNS
r5smallJJparticlesNNS

#Rule:N-HeadNoun
r8LDLLocationAnnotationparticlesNNS

#Rule:HeadNoun-V
r11patternNNisAUX

#Rule:V-HeadNoun
r21haveAUXnumbersNNS

#Rule:PPinNP
r26numbersNNSofINparticlesNNS
r26numbersNNSofINparticlesNNS

# Having small LDL particles, though common, is an unhealthy pattern;
#(S1 (S (S (VP (AUXG Having) (NP (JJ small) (NNP LDL) (NNS particles)))) (, ,) (SBAR (IN though) (S (ADJP (JJ common)))) (, ,) (VP (AUX is) (NP (DT an) (JJ unhealthy) (NN pattern))) (: ;)))
#Rule:Nouns
r1LDLLocationAnnotation
r1particlesNNS
r1patternNN

#Rule:Adjs
r4smallJJ
r4commonJJ
r4unhealthyJJ

#Rule:Adj-Noun
r5smallJJparticlesNNS
r5unhealthyJJpatternNN

#Rule:N-HeadNoun
r8LDLLocationAnnotationparticlesNNS

#Rule:V-HeadNoun
r21HavingAUXGparticlesNNS
r21isAUXpatternNN

# high concentrations of small LDL particles (even though potentially carrying the same total cholesterol content as a low concentration of large particles) correlates with much faster growth of atheroma, progression of atherosclerosis and earlier and more severe cardiovascular disease events and death..LDL
#(S1 (NP (NP (NP (JJ high) (NNS concentrations)) (PP (IN of) (NP (JJ small) (NNP LDL) (NNS particles)))) (PRN (-LRB- -LRB-) (PP (RB even) (IN though) (S (ADVP (RB potentially)) (VP (VBG carrying) (NP (NP (DT the) (JJ same) (JJ total) (NN cholesterol) (NN content)) (PP (IN as) (NP (NP (DT a) (JJ low) (NN concentration)) (PP (IN of) (NP (JJ large) (NNS particles))))))))) (-RRB- -RRB-)) (NP (NP (NNS correlates)) (PP (IN with) (NP (NP (NP (ADJP (RB much) (JJR faster)) (NN growth)) (PP (IN of) (NP (NN atheroma)))) (, ,) (NP (NP (NN progression)) (PP (IN of) (NP (NN atherosclerosis)))) (CC and) (NP (NP (ADJP (JJR earlier) (CC and) (JJR more)) (JJ severe) (JJ cardiovascular) (NN disease) (NNS events) (CC and) (NN death) (NNS ..)) (NP (NNP LDL))))))))
#Rule:Nouns
r1concentrationsNNS
r1LDLLocationAnnotation
r1particlesNNS
r1cholesterolNN
r1contentNN
r1concentrationNN
r1particlesNNS
r1correlatesNNS
r1growthNN
r1atheromaLocationAnnotation
r1progressionNN
r1atherosclerosisNN
r1diseaseNN
r1eventsNNS
r1deathNN
r1..NNS
r1LDLOrganizationAnnotation

#Rule:Verbs
r2carryingVBG

#Rule:Adjs
r4highJJ
r4smallJJ
r4sameJJ
r4totalJJ
r4lowJJ
r4largeJJ
r4fasterJJR
r4earlierJJR
r4moreJJR
r4severeJJ
r4cardiovascularJJ

#Rule:Adj-Noun
r5highJJconcentrationsNNS
r5smallJJparticlesNNS
r5sameJJcontentNN
r5totalJJcontentNN
r5lowJJconcentrationNN
r5largeJJparticlesNNS
r5fasterJJRgrowthNN
r5earlierJJR..NNS
r5moreJJR..NNS
r5severeJJ..NNS
r5cardiovascularJJ..NNS

#Rule:N-HeadNoun
r8LDLLocationAnnotationparticlesNNS
r8cholesterolNNcontentNN
r8deathNN..NNS

#Rule:N-Noun
r9diseaseNNeventsNNS

#Rule:N-ApposN
r10growthNNprogressionNN

#Rule:V-HeadNoun
r21carryingVBGcontentNN

#Rule:PPinNP
r26concentrationsNNSofINparticlesNNS
r26contentNNasINconcentrationNN
r26concentrationNNofINparticlesNNS
r26correlatesNNSwithINgrowthNN
r26correlatesNNSwithINprogressionNN
r26correlatesNNSwithIN..NNS
r26correlatesNNSwithINLDLOrganizationAnnotation
r26growthNNofINatheromaLocationAnnotation
r26progressionNNofINatherosclerosisNN

#Rule:V-ADV
r46carryingVBGpotentiallyRB

#LDL is formed as VLDL lipoproteins lose triglyceride through the action of lipoprotein lipase (LPL) and become smaller and denser, containing a higher proportion of cholesterol..
#(S1 (S (NP (NNP LDL)) (VP (AUX is) (VP (VBN formed) (PP (IN as) (S (S (NP (NNP VLDL) (NNS lipoproteins)) (VP (VP (VBP lose) (NP (NN triglyceride)) (PP (IN through) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NP (FW lipoprotein) (FW lipase)) (PRN (-LRB- -LRB-) (NP (NNP LPL)) (-RRB- -RRB-))))))) (CC and) (VP (VBP become) (ADJP (JJR smaller) (CC and) (JJR denser))))) (, ,) (VP (VBG containing) (NP (NP (DT a) (JJR higher) (NN proportion)) (PP (IN of) (NP (NN cholesterol))))) (. .))))) (. .)))
#Rule:Nouns
r1LDLOrganizationAnnotation
r1VLDLOrganizationAnnotation
r1lipoproteinsNNS
r1triglycerideNN
r1actionNN
r1LPLOrganizationAnnotation
r1proportionNN
r1cholesterolNN

#Rule:Verbs
r2formedVBN
r2loseVBP
r2becomeVBP
r2containingVBG

#Rule:Adjs
r4smallerJJR
r4denserJJR
r4higherJJR

#Rule:Adj-Noun
r5higherJJRproportionNN

#Rule:N-HeadNoun
r8VLDLOrganizationAnnotationlipoproteinsNNS

#Rule:HeadNoun-V
r11lipoproteinsNNSloseVBP
r11lipoproteinsNNSbecomeVBP

#Rule:V-HeadNoun
r21loseVBPtriglycerideNN
r21containingVBGproportionNN

#Rule:V-HeadNoun(passive)
r23formedVBNLDLOrganizationAnnotation

#Rule:PPinNP
r26actionNNofINlipaseFW
r26proportionNNofINcholesterolNN

#Rule:PPinVP
r30loseVBPthroughINactionNN

#A hereditary form of high LDL is familial hypercholesterolemia (FH).
#(S1 (S (NP (NP (DT A) (JJ hereditary) (NN form)) (PP (IN of) (NP (JJ high) (NNS LDL)))) (VP (AUX is) (NP (NP (JJ familial) (NN hypercholesterolemia)) (PRN (-LRB- -LRB-) (NP (NNP FH)) (-RRB- -RRB-)))) (. .)))
#Rule:Nouns
r1formNN
r1LDLOrganizationAnnotation
r1hypercholesterolemiaNN
r1FHOrganizationAnnotation

#Rule:Adjs
r4hereditaryJJ
r4highJJ
r4familialJJ

#Rule:Adj-Noun
r5hereditaryJJformNN
r5highJJLDLOrganizationAnnotation
r5familialJJhypercholesterolemiaNN

#Rule:HeadNoun-V
r11formNNisAUX

#Rule:V-HeadNoun
r21isAUXhypercholesterolemiaNN

#Rule:PPinNP
r26formNNofINLDLOrganizationAnnotation

#Rule:IS-RULE
r47hypercholesterolemiaNNformNN

# Increased LDL is termed hyperlipoproteinemia type II (after the dated Fredrickson classification).
#(S1 (S (NP (VBN Increased) (NN LDL)) (VP (AUX is) (VP (VBN termed) (S (NP (NP (NN hyperlipoproteinemia) (NN type) (NNP II)) (PRN (-LRB- -LRB-) (PP (IN after) (NP (DT the) (VBN dated) (NNP Fredrickson) (NN classification))) (-RRB- -RRB-)))))) (. .)))
#Rule:Nouns
r1LDLOrganizationAnnotation
r1hyperlipoproteinemiaNN
r1typeNN
r1IINNP
r1FredricksonOrganizationAnnotation
r1classificationNN

#Rule:Verbs
r2increasedVBN
r2termedVBN
r2datedVBN

#Rule:Adj-Noun
r5increasedVBNLDLOrganizationAnnotation
r5datedVBNclassificationNN

#Rule:N-HeadNoun
r8typeNNIINNP
r8hyperlipoproteinemiaNNIINNP
r8FredricksonOrganizationAnnotationclassificationNN

#Rule:V-HeadNoun
r22termedVBNIINNP

#Rule:V-HeadNoun(passive)
r23termedVBNLDLOrganizationAnnotation

#LDL poses a risk for cardiovascular disease when it invades the endothelium and becomes oxidized since the oxidized form is more easily retained by the proteoglycans.
#(S1 (S (NP (NNP LDL)) (VP (VBZ poses) (NP (NP (DT a) (NN risk)) (PP (IN for) (NP (NP (JJ cardiovascular) (NN disease)) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VP (VBZ invades) (NP (DT the) (NN endothelium))) (CC and) (VP (VBZ becomes) (ADJP (VBN oxidized) (SBAR (IN since) (S (NP (DT the) (JJ oxidized) (NN form)) (VP (AUX is) (VP (ADVP (RBR more) (RB easily)) (VBN retained) (PP (IN by) (NP (DT the) (NNS proteoglycans)))))))))))))))) (. .)))
#Rule:Nouns
r1LDLOrganizationAnnotation
r1riskNN
r1diseaseNN
r1endotheliumNN
r1formNN
r1proteoglycansOrganizationAnnotation

#Rule:Verbs
r2posesVBZ
r2invadesVBZ
r2becomesVBZ
r2oxidizedVBN
r2retainedVBN

#Rule:Adjs
r4cardiovascularJJ
r4oxidizedJJ

#Rule:Adj-Noun
r5cardiovascularJJdiseaseNN
r5oxidizedJJformNN

#Rule:HeadNoun-V
r11LDLOrganizationAnnotationposesVBZ
r11itPRPinvadesVBZ
r11itPRPbecomesVBZ

#Rule:V-By-Agent
r13proteoglycansOrganizationAnnotationretainedVBN

#Rule:V-HeadNoun
r21posesVBZriskNN
r21invadesVBZendotheliumNN

#Rule:V-HeadNoun(passive)
r23retainedVBNformNN

#Rule:PPinNP
r26riskNNforINdiseaseNN

#Rule:(SBAR+WHADVP)inNP
r41diseaseNNwhenWRBinvadesVBZ
r41diseaseNNwhenWRBbecomesVBZ

#Rule:V-ADV
r46retainedVBNeasilyRB

# A complex set of biochemical reactions regulates the oxidation of LDL, chiefly stimulated by presence of free radicals in the endothelium.
#(S1 (S (NP (NP (DT A) (JJ complex) (NN set)) (PP (IN of) (NP (JJ biochemical) (NNS reactions)))) (VP (VBZ regulates) (NP (NP (DT the) (NN oxidation)) (PP (IN of) (NP (NP (NNP LDL)) (, ,) (VP (ADVP (RB chiefly)) (VBN stimulated) (PP (IN by) (NP (NP (NN presence)) (PP (IN of) (NP (NP (JJ free) (NNS radicals)) (PP (IN in) (NP (DT the) (NN endothelium)))))))))))) (. .)))
#Rule:Nouns
r1setNN
r1reactionsNNS
r1oxidation of LDLOrganizationAnnotation
r1presenceNN
r1radicalsNNS
r1endotheliumNN

#Rule:Verbs
r2regulatesVBZ
r2stimulatedVBN

#Rule:Adjs
r4complexJJ
r4biochemicalJJ
r4freeJJ

#Rule:Adj-Noun
r5complexJJsetNN
r5biochemicalJJreactionsNNS
r5freeJJradicalsNNS

#Rule:HeadNoun-V
r11setNNregulatesVBZ

#Rule:V-By-Agent
r13presenceNNstimulatedVBN

#Rule:V-HeadNoun
r21regulatesVBZoxidation of LDLOrganizationAnnotation

#Rule:V-HeadNoun(passive)
r24stimulatedVBNoxidation of LDLOrganizationAnnotation

#Rule:PPinNP
r26setNNofINreactionsNNS
r26presenceNNofINradicalsNNS
r26radicalsNNSinINendotheliumNN

#Rule:V-ADV
r46stimulatedVBNchieflyRB

# Nitric oxide down-regulates this oxidation process catalyzed by L-arginine.
#(S1 (S (NP (JJ Nitric) (NN oxide) (NNS down-regulates)) (NP (DT this) (NN oxidation) (NN process)) (VP (VBN catalyzed) (PP (IN by) (NP (NNP L-arginine)))) (. .)))
#Rule:Nouns
r1oxideNN
r1down-regulatesNNS
r1oxidationNN
r1processNN
r1L-arginineOrganizationAnnotation

#Rule:Verbs
r2catalyzedVBN

#Rule:Adjs
r4NitricOrganizationAnnotation

#Rule:Adj-Noun
r5NitricOrganizationAnnotationdown-regulatesNNS

#Rule:N-HeadNoun
r8oxideNNdown-regulatesNNS
r8oxidationNNprocessNN

#Rule:V-By-Agent
r13L-arginineOrganizationAnnotationcatalyzedVBN

#Rule:V-HeadNoun(passive)
r24catalyzedVBNdown-regulatesNNS
r24catalyzedVBNprocessNN

# Correspondingly when there are high levels of asymmetric dimethylarginine in the endothelium, production of nitric oxide is inhibited and more LDL oxidation occursBecause LDL appears to be harmless until oxidized by free radicals , it is postulated that ingesting antioxidants and minimizing free radical exposure may reduce LDL s contribution to atherosclerosis, though results are not conclusive.
#(S1 (S (SBAR (WHADVP (RB Correspondingly) (WRB when)) (S (NP (EX there)) (VP (AUX are) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (JJ asymmetric) (NN dimethylarginine))) (PP (IN in) (NP (DT the) (NN endothelium))))))) (, ,) (NP (NP (NN production)) (PP (IN of) (NP (JJ nitric) (NN oxide)))) (VP (AUX is) (VP (VBD inhibited) (SBAR (S (NP (QP (CC and) (JJR more)) (NNP LDL) (FW oxidation) (FW occursBecause) (NNP LDL)) (VP (VBZ appears) (S (VP (TO to) (VP (AUX be) (ADJP (JJ harmless)) (SBAR (IN until) (S (S (VP (VBN oxidized) (PP (IN by) (NP (JJ free) (NNS radicals))))) (, ,) (NP (PRP it)) (VP (AUX is) (VP (VBN postulated) (SBAR (IN that) (S (NP (NP (VBG ingesting) (NNS antioxidants)) (CC and) (NP (VBG minimizing) (JJ free) (JJ radical) (NN exposure))) (VP (MD may) (VP (VB reduce) (NP (NP (NNP LDL) (NNP s) (NN contribution)) (PP (TO to) (NP (NN atherosclerosis)))) (, ,) (SBAR (IN though) (S (NP (NNS results)) (VP (AUX are) (RB not) (ADJP (JJ conclusive))))))))))))))))))))) (. .)))
#Rule:Nouns
r1levelsNNS
r1dimethylarginineNN
r1endotheliumLocationAnnotation
r1productionNN
r1oxideNN
r1LDL oxidationOrganizationAnnotation
r1LDLOrganizationAnnotation
r1radicalsNNS
r1antioxidantsNNS
r1exposureNN
r1LDLOrganizationAnnotation
r1sNNP
r1contributionNN
r1atherosclerosisNN
r1resultsNNS

#Rule:Verbs
r2inhibitedVBD
r2appearsVBZ
r2oxidizedVBN
r2postulatedVBN
r2ingestingVBG
r2minimizingVBG
r2reduceVB

#Rule:Adjs
r4highJJ
r4asymmetricJJ
r4nitricOrganizationAnnotation
r4moreJJR
r4harmlessJJ
r4freeJJ
r4freeJJ
r4radicalJJ
r4conclusiveJJ

#Rule:Adj-Noun
r5highJJlevelsNNS
r5asymmetricJJdimethylarginineNN
r5nitricOrganizationAnnotationoxideNN
r5moreJJRLDLOrganizationAnnotation
r5freeJJradicalsNNS
r5ingestingVBGantioxidantsNNS
r5minimizingVBGexposureNN
r5freeJJexposureNN
r5radicalJJexposureNN

#Rule:N-HeadNoun
r8sNNPcontributionNN
r8LDLOrganizationAnnotationcontributionNN

#Rule:HeadNoun-V
r11productionNNinhibitedVBD
r11thereEXareAUX
r11LDLOrganizationAnnotationappearsVBZ
r11antioxidantsNNSreduceVB
r11exposureNNreduceVB
r11resultsNNSareAUX

#Rule:V-By-Agent
r13radicalsNNSoxidizedVBN

#Rule:V-HeadNoun
r21areAUXlevelsNNS
r21reduceVBcontributionNN

#Rule:V-HeadNoun(passive)
r23postulatedVBNitPRP

#Rule:V-ADJ
r25beAUXharmlessJJ
r25areAUXconclusiveJJ

#Rule:PPinNP
r26levelsNNSofINdimethylarginineNN
r26levelsNNSinINendotheliumLocationAnnotation
r26productionNNofINoxideNN
r26contributionNNtoTOatherosclerosisNN

#Rule:(SBAR+WHADVP)inS
r42inhibitedVBDwhenWRBareAUX

#Rule:V-IN-V
r43beAUXuntilINpostulatedVBN
r43postulatedVBNthatINreduceVB
r43reduceVBthoughINareAUX

#Rule:V-ADV
r46areAUXnotRB

@lemmas-left	need	total	appear	correlates	higher	its	production	associate	hyperlipoproteinemia	time	free	Nitric	levels	protein	event	catalyze	asymmetric	contribution	death	stimulated	22	number	content	native	oxidation of LDL	Apo	retain	keeping	low	transported	arteries	lipoproteins	complex	progression	common	events	poses	atherosclerosis	date	apolipoprotein	faster	antioxidants	numbers	]	triglyceride	FH	atheroma	termed	increasing	oxide	s	pattern	presence	ingesting	having	cardiovascular	keep	relate	proportion	invades	familial	change	become	revealed	same	oxidized	catalyzed	family.	amount	lipoprotein	dimethylarginine	be	retained	belongs	cholesterol	reduce	size	VLDL	ldl	associated	arterial	radicals	containing	nitric	fast	particles	large	regulate	result	density	Fredrickson	set	evidence	appears	circles	approx	4536	carrying	aqueous	formed	severe	formation	hypercholesterolemia	Low-density	minimize	stimulate	needed	L-arginine	acid	proteoglycans	there	changing	increase	high	dense	growth	down-regulates	they	residue	stroke	are	plaques	minimizing	inhibit	soluble	carry	Having	citation	heart	amino	form	bad	distribution	cholesterol.	earlier	start	small	residues	reaction	distribution.	particle	pose	transport	starting	plaque	postulate	correlate	molecule	artery	radical	concentration	LPL	acids	b-100	harmless	oxidation	process	degree	hereditary	classification	LDLs	healthy	attack	nm	reveal	single	belong	contains	unhealthy	inhibited	type	LDL oxidation	mass	level	more	results	rare	family	..	action	relates	II	dated	peripheral	postulated	amounts	environment	contain	called	approx.	biochemical	invade	exposure	call	endothelium	conclusive	increased	have	reactions	becomes	contained	circle	disease	healthiest	regulates	smaller	risk	LDL	denser	ingest	antioxidant	fatty	is	it	ii	concentrations	particles[citation	lose	vascular	term	B-100	oxidize	
@lemmas-right	appear	residue	powerfully	stroke	time	are	levels	catalyze	event	plaques	contribution	inhibit	Still	citation	form	stimulated	number	bad	distribution	cholesterol.	not	content	oxidation of LDL	start	them	retain	keeping	arteries	reaction	residues	lipoproteins	progression	events	poses	easily	chiefly	atherosclerosis	distribution.	particle	pose	apolipoprotein	antioxidants	numbers	starting	triglyceride	plaque	postulate	molecule	radical	artery	atheroma	concentration	acids	b-100	harmless	process	oxide	degree	pattern	classification	attack	keep	nm	invades	relate	proportion	reveal	belong	become	revealed	contains	inhibited	actually	oxidized	catalyzed	family.	potentially	level	lipoprotein	dimethylarginine	family	..	action	be	relates	retained	II	belongs	cholesterol	reduce	size	postulated	environment	radicals	contain	approx.	invade	particles	regulate	exposure	endothelium	conclusive	reactions	have	set	becomes	evidence	circle	disease	regulates	appears	risk	circles	LDL	approx	lipase	antioxidant	formation	is	it	thus	hypercholesterolemia	ii	still	concentrations	stimulate	particles[citation	lose	vascular	acid	proteoglycans	B-100	there	oxidize	down-regulates	growth	
@lemmas-center	to	with	for	as	through	in	though	until	of	that	over	inside	than	when	within	